Delisting riskPopularity #4,507
CEL-SCI (CVM)
Develops a pre-surgical cytokine treatment for selected head-and-neck cancer patients.
$1.72
vs last close+0.02 (+1.04%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 29.04% | 2.00M shares | |
|---|---|---|---|
| 40 holders · as of Jun 30, 2026 | |||
| Insiders | 4.60% | 316.1K shares | |
| 1 holder · as of Aug 26, 2026 | |||
| Strategic holders | 8.08% | 555.0K shares | |
| 1 holder · as of Aug 29, 2025 | |||
| Other | 58.28% | 4.00M shares | |
| remainder | |||
6.87M company shares as of Aug 29, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
40 holders · 2.00M shares · 10 new positions · 20 increased · 3 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Renaissance Technologies LLC | 572.5K | 8.33% | +536.6K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 543.1K | 7.90% | +299.4K | Aug 13, 2026 |
| Citadel Advisors LLC | 198.5K | 2.89% | +198.5K | Sep 2, 2026 |
| Mai Capital Management | 108.3K | 1.58% | +17.0K | Aug 14, 2026 |
| Geode Capital Management, LLC | 88.2K | 1.28% | +2.9K | Aug 12, 2026 |
| Commonwealth Equity Services, LLC | 51.4K | 0.75% | +33.8K | Jul 29, 2026 |
| HRT Financial LP | 51.2K | 0.74% | +51.2K | Aug 14, 2026 |
| Vanguard Fiduciary Trust Co | 49.0K | 0.71% | 0 | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Lincoln Alternative Strategies LLC | 6.94% | 555.0K | 13G | Aug 29, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 25, 2026 | Geert R. Kerstendirector, officer: Chief Executive Officer | Purchase | 100,000 | $1.38 | 316,142 |
House and Senate disclosures
Not reported.